Work

PA-341 Patient-Reported Quality of Life and Real-World Outcomes with Use of Daratumumab Regimens in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Multicenter Study

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)03704-3

Authors: Sabrina L. Browning, Fangyong Li, Terri L. Parker, Noffar Bar, Smith Giri, Muhamad Baljevic, Gayathri Ravi, Bin Zhou, Erica Stevens, Jessica Mazzarella, Tara Anderson, Elan Gorshein, Kert Sabbath, Catherine Wei, Syed Ali, Wilson I. Gonsalves, Natalia Neparidze

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7213908861

Cites:

Cited by:

Related to: 10